399 views
New methods for diagnosing the disease in its early stages, monoclonal antibodies under consideration by the EMA, first European guidelines: many results have been achieved after years of scientific research. We talked about it with Annachiara Cagnin, head of the Center for Cognitive Disorders and Dementia at the Neurology Clinic of the Hospital-University of Padua on the occasion of World Brain Week (11-17 March 2024). Report by Monica Panetto Filming and editing by Barbara Paknazar Read the article on Il Bo Live: https://ilbolive.unipd.it/it/news/sal... ----- Follow Il Bo Live on social media! / ► Facebook / ► Instagram